Viewing Study NCT07289503


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-25 @ 5:14 PM
Study NCT ID: NCT07289503
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-12-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-05-27
Start Date Type: ACTUAL
Primary Completion Date: 2025-09-04
Primary Completion Date Type: ACTUAL
Completion Date: 2026-06-27
Completion Date Type: ESTIMATED
First Submit Date: 2025-12-04
First Submit QC Date: None
Study First Post Date: 2025-12-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-04
Last Update Post Date: 2025-12-17
Last Update Post Date Type: ESTIMATED